In Singapore, the medtech sector is booming. From just 59 in 2010, there are now more than 400 medtech companies. The Economic Development Board (EDB) estimates that the market will hit US$225 billion by 2030 in Asia alone.
However, this rapid expansion comes with its own set of challenges, mostly a compliance issue which has stifled innovation.
Last year, the Health Sciences Authority (HSA) in Singapore intensified its efforts to crack down on the illicit trade of health products, resulting in the seizure of over 1.12 million units of illegal items and the removal of more than 12,000 listings from online platforms.
The majority of the removed listings were selling sexual enhancement or male vitality products, hair and beauty products such as anti-hair loss treatment, facial fillers and adulterated skin whitening products.
What’s behind Singapore’s medtech boom
The growth in the medtech sector in Singapore in the past few years has been due to a few key reasons.
The first being the support from the government, as they have been proactive in fostering a conducive environment for such companies. Initiatives like the Biomedical Sciences Industry Development Roadmap and funding support from agencies such as Agency for Science, Technology and Research (A*STAR) and Enterprise Singapore have been crucial.
Secondly, Singapore’s strategic location and connectivity make it an excellent base for companies to set up, thus providing easy access to the regional markets.
Thirdly, HSA ensures that Singapore has a robust regulatory framework with high standards of safety, quality, and efficacy for medical devices. This reliability has bolstered confidence among global medtech firms.
Compliance: A double-edged sword
While HSA’s stringent regulations have enhanced the quality and safety of medtech products, they have also introduced significant compliance challenges.
Also Read: The rise of generative AI in digital mental health solution
As artificial intelligence and digital health technologies evolve, protecting patient data and ensuring cybersecurity have become paramount. Medtech companies are now tasked with adhering to Singapore’s Personal Data Protection Act (PDPA) and implementing robust cybersecurity measures to safeguard sensitive information. This is no small feat and requires significant investment and ongoing vigilance.
Companies must comply with strict guidelines for labelling, advertising, and promotional activities. Ensuring that product claims are substantiated by clinical evidence and that all marketing materials comply with HSA guidelines is essential to prevent misleading information and maintain consumer trust.
Medtech companies cannot afford to be complacent. To stay ahead of regulatory changes, they must establish robust processes to monitor updates from authorities like HSA, the Food and Drug Administration (FDA), and the European Medicines Agency (EMA). Some of the critical steps they need to do is subscribe to regulatory newsletters, attend industry conferences, and engage with regulatory consultants.
Regulatory challenges can have both positive and negative impacts on innovation
This focus on safety can enhance patient outcomes and increase trust in medtech products.
An upside would be having a competitive advantage. Medtech firms that successfully navigate regulatory challenges and obtain approvals can gain a competitive advantage.
Also, being compliant with rigorous regulatory standards can enhance a company’s reputation and credibility in global markets.
However, the cost and time spent complying with regulatory requirements, particularly for smaller medtech firms with limited resources, can be a huge issue. The investment in regulatory compliance may divert resources away from Research and Development (R&D) activities.
Also Read: Solving multiple medtech problems with a single device powered by AI
Another downside would be risk aversion, wherein, in some cases, stringent regulations may discourage risky or novel innovations due to concerns about meeting regulatory standards. This could stifle breakthrough technologies that have the potential to revolutionise healthcare.
Advice for new entrants
For companies looking to enter the Singapore market, understanding regulatory requirements is paramount. Familiarising yourself with HSA’s regulations, including the classification of medical devices, setting up a Quality Management System (QMS), and navigating regulatory pathways for registration, importation, and market approval, is essential.
Another important piece of advice would be to understand the local market needs. The products should be tailored to the healthcare landscape and specific needs of the healthcare providers and patients in Singapore.
Future trends in regulatory requirements
As digital health technologies and AI applications in healthcare continue to evolve, regulatory frameworks must adapt to ensure safety, efficacy, and data privacy. This may involve introducing specific guidelines for digital health and AI-driven medical devices.
With the growing connectivity of medical devices and cybersecurity threats, future regulatory requirements may include stringent measures to ensure cybersecurity resilience. Compliance with data protection regulations, such as Singapore’s PDPA, will also be critical.
With the constant threat of global warming and climate change, regulatory frameworks may incorporate requirements related to the environmental impact of medical devices throughout their lifecycle. This could involve considerations such as eco-design principles, recycling and disposal requirements, and sustainable sourcing of materials.
As the sector evolves, so too must the regulatory frameworks, adapting to new technologies and emerging challenges to sustain Singapore’s position as a global medtech leader. The future of medtech in Singapore is bright, but only if we continue to innovate and adapt to the regulatory landscape.
—
Editor’s note: e27 aims to foster thought leadership by publishing views from the community. Share your opinion by submitting an article, video, podcast, or infographic.
Join our e27 Telegram group, FB community, or like the e27 Facebook page.
Image credit: Canva Pro
The post The future of medtech in Singapore: Innovation amid regulatory challenges appeared first on e27.